anatabine has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ait-Ghezala, G; Beaulieu-Abdelahad, D; Crawford, F; Li, R; Mullan, M; Paris, D; Verma, M | 1 |
| Ait-Ghezala, G; Bachmeier, C; Beaulieu-Abdelahad, D; Bishop, A; Chao, J; Crawford, F; Mathura, V; Mullan, M; Paris, D; Reed, J | 1 |
| Abdullah, L; Ait-Ghezala, G; Bachmeier, C; Beaulieu-Abdelahad, D; Crawford, F; Mullan, M; Paris, D; Reed, J; Verma, M | 1 |
3 other study(ies) available for anatabine and Alzheimer Disease
| Article | Year |
|---|---|
Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
Topics: Alkaloids; Alzheimer Disease; Animals; Behavior, Animal; Disease Models, Animal; Mice; Mice, Transgenic; Nerve Tissue Proteins; Pyridines; Social Behavior | 2015 |
Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; CHO Cells; Cricetinae; Cricetulus; Gene Expression Regulation; HEK293 Cells; Humans; Mice; Mice, Transgenic; NF-kappa B; Pyridines | 2011 |
Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.
Topics: Alkaloids; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cytokines; HEK293 Cells; Humans; Inflammation; Mice; Mice, Inbred C57BL; Phosphorylation; Pyridines; STAT3 Transcription Factor | 2013 |